Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lan Zhaketong capsule for hyperlipidemia
CTR20130234Phase 2Completed
- Sponsor
- Sichuan Pearl Pharmaceutical
- Start
- Apr 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lan zhaketong in hyperlipidemia, sponsored by Sichuan Pearl Pharmaceutical. Started Apr 2014; status: completed.
02
Drugs
lan zhaketong
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on CTR20130234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130234.